Telehealth platform American Well has raised $291m of a planned $315m round, the investors including strategic partner Philips.

Leiden thrombosis therapy spinout VarmX had raised an undisclosed seed sum in June 2017 and converted debt to equity in its latest round.

The cancer drug developer and Stanford spinout floated at the top of its range in an offering that could reach $129m.

Health insurance platform Bind has raised funding from a consortium featuring strategic partner UnitedHealthcare and Ascension Ventures.

The cancer therapy developer has closed an $11.1m series A round featuring M Ventures and seed-stage backer Novo Seeds.

The GV-backed cancer drug developer floated at the top of its range in an offering that could reach $129m.

Tasly Pharmaceuticals contributed to a series C round for the immunotherapy developer, a year after backing its $150m series B.

Precision oncological diagnostics developer Clearbridge BioMedics is planning to float, almost a decade after it was spun out from National University of Singapore and Smart Centre.

The SoftBank-backed genetic liquid biopsy technology developer has raised a nine-figure renminbi amount in a Shenzhen Capital-led round.